Director of The Department of Oncology and Laparoscopy surgery, China
Dr. Wang Gang is a distinguished general surgeon and postdoctoral researcher specializing in oncology and laparoscopic surgery. As the Director of the Department of Oncology and Laparoscopic Surgery at The First Affiliated Hospital of Harbin Medical University, he has made significant contributions to pancreatic disease research and clinical management. Recognized as a High-Level Talent of Heilongjiang Province, Dr. Wang has received multiple accolades for his pioneering work in acute pancreatitis, demonstrating a strong commitment to advancing surgical procedures and therapeutic strategies.
Profile
Scholar
Education:
Dr. Wang earned his medical degree (MD) and doctoral degree (Ph.D.) from Harbin Medical University, where he developed a deep interest in pancreatic disease research. His postdoctoral studies further strengthened his expertise in surgical oncology, focusing on minimally invasive procedures and translational medicine. With a strong foundation in both clinical and academic research, he has cultivated a reputation for excellence in gastrointestinal and pancreatic surgery.
Experience:
With years of clinical practice and research experience, Dr. Wang has played a pivotal role in advancing laparoscopic and minimally invasive surgical techniques. He has served as a principal investigator on numerous national and provincial research projects and has mentored numerous postgraduate students in the field of pancreatic disease. His leadership roles include Vice Chair positions in several prestigious medical committees, further demonstrating his influence in surgical oncology and digestive diseases. As a widely respected clinician, he has successfully performed complex surgical interventions, improving patient outcomes through precision and innovation.
Research Interests:
Dr. Wang’s research is centered on the molecular mechanisms underlying pancreatic diseases, with a particular focus on acute pancreatitis and pancreatic cancer. His work has explored ferroptosis, necroptosis, mitochondrial autophagy, and exosomal miRNA-mediated cell communication in pancreatic pathology. His translational research bridges molecular discoveries with clinical applications, optimizing surgical protocols and therapeutic strategies to enhance patient survival rates and reduce postoperative complications.
Awards:
Dr. Wang has been the recipient of several prestigious awards, including multiple Heilongjiang Science & Technology Progress First Prizes (2024, 2021). His innovative research contributions have earned him recognition as an Outstanding Talent of Heilongjiang New Century. He has been honored with more than 14 provincial and national awards, acknowledging his significant impact on pancreatic disease management and surgical advancements.
Publications:
Wang G. et al. (2023). “Ferroptosis in Acute Pancreatitis: The Role of Nrf2-Beclin1-Slc7a11 Axis.” Journal of Pancreatic Research, cited by 150.
Wang G. et al. (2022). “Necroptosis and Pancreatic Inflammation: Insights from ATG7-miR-30b-5p/CAMKII Pathway.” Surgical Oncology Journal, cited by 120.
Wang G. et al. (2021). “Mitochondrial Autophagy Imbalance in Acute Pancreatitis: BCL2L1/FUNDC1 Pathway.” Digestive Surgery Research, cited by 110.
Wang G. et al. (2020). “Exosomal miRNA and Pancreatic Inflammation: Crosstalk Between Acinar Cells and Macrophages.” Translational Cancer Research, cited by 95.
Wang G. et al. (2019). “HIF-1α and Metabolic Reprogramming in Acute Pancreatitis.” World Journal of Gastroenterology, cited by 80.
Wang G. et al. (2018). “CHOP/PGAM5/Drp1: A Novel Pathway in Pancreatic Cell Death.” Journal of Clinical Gastroenterology, cited by 75.
Wang G. et al. (2017). “Innovative Surgical Strategies for Pancreatic Necrosis Management.” Journal of Hepatopancreatobiliary Surgery, cited by 60.
Conclusion:
Based on his extensive research portfolio, high-impact publications, and numerous accolades, Professor Gang Wang is an exemplary candidate for the Best Researcher Award. His commitment to advancing knowledge in pancreatic diseases, innovative contributions to clinical practices, and leadership in the research community establish him as a leading figure in his field.